医院整合对即刻乳房重建住院费用与结局的影响
该研究基于2009至2011年全国住院患者样本,对接受乳房切除后即刻乳房重建的私人保险女性患者进行回顾性横断面分析,采用Herfindahl-Hirschman指数衡量医院市场竞争程度。结果显示,市场竞争减弱与住院费用降低相关,而住院并发症和延长住院时间与竞争程度无关联。
要点
- 市场竞争越弱,即刻乳房重建的住院费用和程序加价越低。
- 市场每增加5家医院,游离皮瓣重建调整后费用高6.6%,非游离皮瓣高5.1%。
- 住院并发症和延长住院时间与医院市场竞争程度无关联。
核心结论
- 市场竞争减弱与较低的住院费用相关,临床结局无差异,提示医院合并带来的规模经济等效率可能以较低费用传递给支付方和患者。
研究设计与样本
- 回顾性横断面分析,使用2009至2011年Nationwide Inpatient Sample中接受乳房切除后即刻乳房重建的私人保险女性患者,加权总计42,411例,其中5920例(14.0%)接受游离皮瓣重建。
- 以Herfindahl-Hirschman指数描述医院市场竞争,采用分层模型调整患者、医院和市场特征后分析结局关联。
主要发现
- 非竞争市场中6.8%(n=857)接受游离皮瓣重建,高竞争市场为13.6%(n=2773),中等竞争市场为24.6%(n=2290)。
- 市场每增加5家医院,游离皮瓣重建调整后费用高6.6%(95%CI:2.8%-10.5%),非游离皮瓣重建高5.1%(95%CI:2.0%-8.4%)。
- 市场竞争增加与程序加价升高相关:非游离皮瓣重建增加5.5%(95%CI:1.1%-10.1%),游离皮瓣重建增加8.2%(95%CI:1.8%-15.0%)。
- 游离皮瓣或非游离皮瓣重建患者的住院并发症发生率或延长住院时间与医院市场竞争之间无关联。
临床怎么用
- 在评估乳房重建的医院选择与费用控制时,可关注医院所在市场的竞争程度及其对住院费用的影响。
- 医院整合可能降低即刻乳房重建的住院费用,但需结合临床结局综合判断。
局限性
- 研究为回顾性横断面分析,仅纳入2009至2011年私人保险女性患者,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To examine the relationship between hospital market competition and inpatient costs, procedural markup, inpatient complications, and length of stay among privately insured patients undergoing immediate reconstruction after mastectomy. METHODS: A retrospective cross-sectional analysis of privately insured female patients undergoing immediate breast reconstruction in the 2009 to 2011 Nationwide Inpatient Sample was performed. The Herfindahl-Hirschman index was used to describe hospital market competition; associations with outcomes were explored via hierarchical models adjusting for patient, hospital, and market characteristics. RESULTS: A weighted total of 42,411 patients were identified; 5920 (14.0%) underwent free flap reconstruction. In uncompetitive markets, 6.8% (n=857) underwent free flap reconstruction, compared with 13.6% (n=2773) in highly competitive markets and 24.6% (n=2290) in moderately competitive markets. For every 5 additional hospitals in a market, adjusted costs were 6.6% higher (95% CI: 2.8%-10.5%), for free flap reconstruction, and 5.1% higher (95% CI: 2.0%-8.4%) for nonfree flap reconstruction. Similarly, higher procedural markup was associated with increased hospital market competition both for nonfree flap reconstruction (5.5% increase, 95% CI: 1.1%-10.1%) and for free flap reconstruction (8.2% increase, 95% CI: 1.8%-15.0%). Notably, there was no association between incidence of inpatient complications or extended length of stay and hospital market competition among either free flap or nonfree flap reconstruction patients. CONCLUSIONS: Decreasing market competition was associated with lower inpatient costs and equivocal clinical outcomes. This suggests that some of the economies of scale, access to capital and care delivery efficiencies gained from increased market power following hospital mergers are passed onto payers and consumers as lower costs.
引用
- Cerullo M, Sheckter CC, Canner JK, et al. Is Bigger Better?: The Effect of Hospital Consolidation on Index Hospitalization Costs and Outcomes Among Privately Insured Recipients of Immediate Breast Reconstruction. Ann Surg. 2019. PMID: 31356269. doi:10.1097/SLA.0000000000003481
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。